LungVision™IntegrationContact Us

LungVision™ AI-Driven, Intraoperative CT Imaging

A Breakthrough Innovation in Lung Cancer Diagnostics

LungVision™ AI-Driven, Intraoperative CT Imaging

A Breakthrough Innovation in Lung Cancer Diagnostics


LungVision™ by Body Vision Medical

A Breakthrough Innovation in Lung Cancer Diagnostics

Clinically Effective
  • Provides the near-CBCT intraoperative imaging required to overcome CT-to-body divergence, enable tool-in-lesion confirmation, and drive diagnostic yields to 90%
Easy to Deploy
  • Works with your existing C-arm and bronchoscopy platform
  • Can be used standalone for image-guided navigation and biopsy or…
  • Enhances any robot bronchoscopy platform with real-time imaging
Economical
  • Lower capital and per-case costs than ENB, Robotics, or CBCT means LungVIsion™ can reduce costs and make diagnostic bronchoscopy a profitable procedure

Our Advantages

94
.5%

Diagnostic Yield

50
%

Cost savings per Case

$
5
K

Contribution Margin per Case

Improve Your Diagnostic Yield

LungVision’s C-Arm Based Tomography (CABT) technology produces real-time, intraoperative 3D imaging with any conventional C-Arm. This enables precise navigation to the actual lesion location and visual confirmation of tool-in-lesion so that you can biopsy with confidence.

  • Achieved up to 94.5% diagnostic yield with robotics¹
  • Achieved up to 89.0% diagnostic yield standalone¹

Freedom to Work with the Technologies of Your Choice

Any Tool, Any Room, Any Lesion

The LungVision™ system seamlessly integrates with most C-arms, navigation systems, biopsy tools, and bronchoscopes - including robotic bronchoscopy platforms - that you may already have in the procedure room.


Financial Benefits

Cost-per-case potentially 50% that of existing navigation platform.

A fraction of the cost of robotics, cone-beam CT and alternative technologies.

Grow lung nodule program by increasing biopsy case volume by 40% or more.

Higher diagnosis rate = greater patient retention and downstream revenue.

Testimonials

Author

“We use Body Vision in every navigation case, including robotic bronchoscopy cases. It gives you the confidence to go after the most difficult lesions because, for the first time ever, you can see the real lesion.”

Dr. Kyle Hogarth
FCCP Professor of Medicine, Director of Bronchoscopy, University of Chicago, IL
Author

“If you can give every single bronchoscopy suite a real-time, near-CT quality confirmation of the tool-in-lesion, you effectively change the entire dynamic of the market and pulmonary practice as it is today. In its essence, LungVision™ is a disruptive imaging technology far beyond just the navigation. It is fantastic, what it can do!”

Dr. George Cheng
Interventional Pulmonologist San Diego, CA
Author

“Body Vision’s ability to produce tomography from any C-Arm and ensure in 3D that you’re right where you are supposed to be prior to and during biopsy is so unique and clearly improves my diagnostic yield.”

Dr. Nina Maouelainin
Interventional Pulmonologist CEO/Founder at Lung Health Services Interventional Pulmonology
Author

“In most cases, Body Vision provides me with the same confidence as CBCT. Even better, in fact, since I don't need to leave the room. I can keep the scope at the exact position pointing at the lesion and confirm tool-in-lesion right before biopsy.”

Dr. Amir Abramovich
Director, Interventional Pulmonology Carmel Medical Center
Author

“The flexibility of being able to adapt any tool in my armamentarium to sample the lung lesion with advanced intraoperative CT imaging that helps me see my tool and the lesion in 3D gives me confidence to sample the lesion for a definitive diagnosis.”

Dr. Roshen Mathew
Interventional Pulmonologist WVU Camden Clark Medical Center Parkersburg, WV
Author

“With Body Vision, our ability to correct for CT-to-body divergence, especially in small, sub-centimeter and centimeter lesions is game changing.”

Dr. Joseph D. Whitlark
Robotic Thoracic Surgeon Crozer Health

Contact Us Today!


Contact Body Vision Medical

Get in touch with us for information about acquiring LungVision™, the latest product updates, company news and more. A member of our team will be in touch shortly.

© 2023 Body Vision Medical Ltd. All rights reserved

© 2023 Body Vision Medical Ltd. All rights reserved

Contact Body
Vision Medical

Please fill out the form to get started.

GET FREE DEMO

Please fill out the form to get started.

  • Andorra(+376)
  • United Arab Emirates(+971)
  • Afghanistan(+93)
  • Antigua & Barbuda(+1 268)
  • Anguilla(+1 264)
  • Albania(+355)
  • Armenia(+374)
  • Angola(+244)
  • Antarctica(+8)
  • Argentina(+54)
  • Samoa (American)(+1 684)
  • Austria(+43)
  • Australia(+61)
  • Aruba(+297)
  • Åland Islands(+358 18)
  • Azerbaijan(+994)
  • Bosnia & Herzegovina(+387)
  • Barbados(+1 246)
  • Bangladesh(+880)
  • Belgium(+32)
  • Burkina Faso(+226)
  • Bulgaria(+359)
  • Bahrain(+973)
  • Burundi(+257)
  • Benin(+229)
  • St Barthelemy(+590)
  • Bermuda(+1 441)
  • Brunei(+673)
  • Bolivia(+591)
  • Caribbean NL(+599)
  • Brazil(+55)
  • Bahamas(+1 242)
  • Bhutan(+975)
  • Botswana(+267)
  • Belarus(+375)
  • Belize(+501)
  • Canada(+1)
  • Cocos (Keeling) Islands(+61)
  • Congo (Dem. Rep.)(+243)
  • Central African Rep.(+236)
  • Congo (Rep.)(+242)
  • Switzerland(+41)
  • Côte d'Ivoire(+225)
  • Cook Islands(+682)
  • Chile(+56)
  • Cameroon(+237)
  • China(+86)
  • Colombia(+57)
  • Costa Rica(+506)
  • Cuba(+53)
  • Cape Verde(+238)
  • Curaçao(+599)
  • Christmas Island(+61)
  • Cyprus(+357)
  • Czech Republic(+420)
  • Germany(+49)
  • Djibouti(+253)
  • Denmark(+45)
  • Dominica(+1 767)
  • Dominican Republic(+1 809)
  • Algeria(+213)
  • Ecuador(+593)
  • Estonia(+372)
  • Egypt(+20)
  • Western Sahara(+212)
  • Eritrea(+291)
  • Spain(+34)
  • Ethiopia(+251)
  • Finland(+358)
  • Fiji(+679)
  • Falkland Islands(+500)
  • Micronesia(+691)
  • Faroe Islands(+298)
  • France(+33)
  • Gabon(+241)
  • Britain (UK)(+44)
  • Grenada(+1 473)
  • Georgia(+995)
  • French Guiana(+594)
  • Guernsey(+44 1481)
  • Ghana(+233)
  • Gibraltar(+350)
  • Greenland(+299)
  • Gambia(+220)
  • Guinea(+224)
  • Guadeloupe(+590)
  • Equatorial Guinea(+240)
  • Greece(+30)
  • South Georgia & the South Sandwich Islands(+99)
  • Guatemala(+502)
  • Guam(+1 671)
  • Guinea-Bissau(+245)
  • Guyana(+592)
  • Hong Kong(+852)
  • Honduras(+504)
  • Croatia(+385)
  • Haiti(+509)
  • Hungary(+36)
  • Indonesia(+62)
  • Ireland(+353)
  • Israel(+972)
  • Isle of Man(+44 1624)
  • India(+91)
  • British Indian Ocean Territory(+246)
  • Iraq(+964)
  • Iran(+98)
  • Iceland(+354)
  • Italy(+39)
  • Jersey(+44 1534)
  • Jamaica(+1 876)
  • Jordan(+962)
  • Japan(+81)
  • Kenya(+254)
  • Kyrgyzstan(+996)
  • Cambodia(+855)
  • Kiribati(+686)
  • Comoros(+269)
  • St Kitts & Nevis(+1 869)
  • Korea (North)(+850)
  • Korea (South)(+82)
  • Kuwait(+965)
  • Cayman Islands(+1 345)
  • Kazakhstan(+7)
  • Laos(+856)
  • Lebanon(+961)
  • St Lucia(+1 758)
  • Liechtenstein(+423)
  • Sri Lanka(+94)
  • Liberia(+231)
  • Lesotho(+266)
  • Lithuania(+370)
  • Luxembourg(+352)
  • Latvia(+371)
  • Libya(+218)
  • Morocco(+212)
  • Monaco(+377)
  • Moldova(+373)
  • Montenegro(+382)
  • St Martin (French)(+590)
  • Madagascar(+261)
  • Marshall Islands(+692)
  • North Macedonia(+389)
  • Mali(+223)
  • Myanmar (Burma)(+95)
  • Mongolia(+976)
  • Macau(+853)
  • Northern Mariana Islands(+ 1 670)
  • Martinique(+596)
  • Mauritania(+222)
  • Montserrat(+1 664)
  • Malta(+356)
  • Mauritius(+230)
  • Maldives(+960)
  • Malawi(+265)
  • Mexico(+52)
  • Malaysia(+60)
  • Mozambique(+258)
  • Namibia(+264)
  • New Caledonia(+687)
  • Niger(+227)
  • Norfolk Island(+672)
  • Nigeria(+234)
  • Nicaragua(+505)
  • Netherlands(+31)
  • Norway(+47)
  • Nepal(+977)
  • Nauru(+674)
  • Niue(+683)
  • New Zealand(+64)
  • Oman(+968)
  • Panama(+507)
  • Peru(+51)
  • French Polynesia(+689)
  • Papua New Guinea(+675)
  • Philippines(+63)
  • Pakistan(+92)
  • Poland(+48)
  • St Pierre & Miquelon(+508)
  • Pitcairn(+870)
  • Puerto Rico(+1 787)
  • Palestine(+970)
  • Portugal(+351)
  • Palau(+680)
  • Paraguay(+595)
  • Qatar(+974)
  • Réunion(+262)
  • Romania(+40)
  • Serbia(+381)
  • Russia(+7)
  • Rwanda(+250)
  • Saudi Arabia(+966)
  • Solomon Islands(+677)
  • Seychelles(+248)
  • Sudan(+249)
  • Sweden(+46)
  • Singapore(+65)
  • St Helena(+290)
  • Slovenia(+386)
  • Svalbard & Jan Mayen(+47)
  • Slovakia(+421)
  • Sierra Leone(+232)
  • San Marino(+378)
  • Senegal(+221)
  • Somalia(+252)
  • Suriname(+597)
  • South Sudan(+211)
  • Sao Tome & Principe(+239)
  • El Salvador(+503)
  • St Maarten (Dutch)(+599)
  • Syria(+963)
  • Eswatini (Swaziland)(+268)
  • Turks & Caicos Is(+1 649)
  • Chad(+235)
  • French Southern Territories(+99)
  • Togo(+228)
  • Thailand(+66)
  • Tajikistan(+992)
  • Tokelau(+690)
  • East Timor(+670)
  • Turkmenistan(+993)
  • Tunisia(+216)
  • Tonga(+676)
  • Turkey(+90)
  • Trinidad & Tobago(+1 868)
  • Tuvalu(+688)
  • Taiwan(+886)
  • Tanzania(+255)
  • Ukraine(+380)
  • Uganda(+256)
  • US minor outlying islands(+1)
  • United States(+1)
  • Uruguay(+598)
  • Uzbekistan(+998)
  • Vatican City(+379)
  • St Vincent(+1 784)
  • Venezuela(+58)
  • Virgin Islands (UK)(+1 284)
  • Virgin Islands (US)(+1 340)
  • Vietnam(+84)
  • Vanuatu(+678)
  • Wallis & Futuna(+681)
  • Samoa (western)(+685)
  • Yemen(+967)
  • Mayotte(+262)
  • South Africa(+27)
  • Zambia(+260)
  • Zimbabwe(+263)
Please fill all the required fields!
Please accept terms and conditions to proceed

Book an Appointment

Please fill out the form to get started.

Please wait